» Articles » PMID: 11447743

Immunohistochemical Expression of Human Erythrocyte Glucose Transporter and Fatty Acid Synthase in Infiltrating Breast Carcinomas and Adjacent Typical/atypical Hyperplastic or Normal Breast Tissue

Overview
Specialty Pathology
Date 2001 Jul 13
PMID 11447743
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the immunohistochemical expression of GLUT1, human erythrocyte glucose transporter 1, and fatty acid synthase (FAS), 66 human breast carcinomas and adjacent peritumoral tissue were studied. GLUT1 and FAS were expressed in 53 and 61 carcinomas, in 17 and 14 typical/atypical hyperplastic tissues, and in 16 and 13 tissues adjacent to tumor normal breast tissue, respectively. Statistical analysis revealed association between invasive carcinomas, invasive carcinomas with in situ component and GLUT1 immunostaining. GLUT1 staining was associated with tumor grade, FAS with tumor stage, and GLUT1 and FAS coexpression with tumor grade. Controls expressed no immunostaining. GLUT1 and FAS are new markers involved in the biologic activities of cancer cells. GLUT1 and FAS coexpression may indicate increased use of energy by the neoplastic cells correlated with poorly differentiated features and aggressive behavior. The innovative finding that GLUT1 and FAS are observed in mammary carcinoma adjacent nonneoplastic tissues may suggest a role in detecting initial phases of breast carcinogenesis.

Citing Articles

Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells.

Ward A, Riley D, Cosper K, Finlay-Schultz J, Brechbuhl H, Libby A Breast Cancer Res. 2025; 27(1):32.

PMID: 40055794 PMC: 11889759. DOI: 10.1186/s13058-025-01991-1.


An arrayed CRISPR knockout screen identifies genetic regulators of GLUT1 expression.

Shi Y, Katdare K, Kim H, Rosch J, Neal E, Vafaie-Partin S Sci Rep. 2023; 13(1):21038.

PMID: 38030680 PMC: 10687026. DOI: 10.1038/s41598-023-48361-5.


OBHS Drives Abnormal Glycometabolis Reprogramming via GLUT1 in Breast Cancer.

Wang K, Li Q, Fan Y, Fang P, Zhou H, Huang J Int J Mol Sci. 2023; 24(8).

PMID: 37108300 PMC: 10138908. DOI: 10.3390/ijms24087136.


Progesterone Receptor-Mediated Regulation of Cellular Glucose and F-Fluorodeoxyglucose Uptake in Breast Cancer.

Salem K, Reese R, Alarid E, Fowler A J Endocr Soc. 2023; 7(2):bvac186.

PMID: 36601022 PMC: 9795483. DOI: 10.1210/jendso/bvac186.


GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancer.

Zeng K, Ju G, Wang H, Huang J Transl Cancer Res. 2022; 9(4):2363-2377.

PMID: 35117597 PMC: 8797933. DOI: 10.21037/tcr.2020.03.50.